CFO transition
Fortrea Holdings Inc. CFO transition: Jason Knoblauch to succeed Jill McConnell
Fortrea Holdings Inc. reported in a Form 8-K filed June 26, 2026 that Jason Knoblauch will succeed Jill McConnell as Chief Financial Officer, effective July 6, 2026.
In the filing's words
Fortrea Holdings Inc. (the “Company”) has appointed Jason Knoblauch as the Company’s Chief Financial Officer, effective July 6, 2026 (the “Transition Date”). He will succeed Jill McConnell, who is stepping down as Chief Financial Officer on the Transition Date but intends to remain employed with the Company for a transition period.
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | Fortrea Holdings Inc. (FTRE) |
|---|---|
| Event | Transition |
| Incoming | Jason Knoblauch |
| Outgoing | Jill McConnell |
| Title in the filing | Chief Financial Officer |
| Effective | July 6, 2026 |
| 8-K filed | June 26, 2026 |
| Internal promotion | No |
| Prior role (per filing) | Executive Vice President and Chief Financial Officer, Clario |
| SEC CIK | 0001965040 |
Fortrea Holdings Inc. reported this change in a Form 8-K, Item 5.02, filed June 26, 2026. The filing's own words are quoted above.
Other records naming Jill McConnell
1The outgoing officer on this record, matched by name. Career line.
2026-02-26 · 10-K signature
Jill McConnell signed Fortrea Holdings Inc.'s annual report as Chief Financial Officer (Principal Financial Officer)
Also filed in June 2026
Other CFO moves on the record that month. All moves.
4 months ago· 2026-06-30TransitionBANX
ArrowMark Financial Corp. CFO transition: Katherine Jones to succeed Patrick Farrell
4 months ago· 2026-06-30InterimIMNN
Imunon, Inc. names Josh Blacher interim CFO
4 months ago· 2026-06-30TransitionRANI
Rani Therapeutics Holdings, Inc. CFO transition: Nicholas M. Maestas to succeed Svai Sanford
4 months ago· 2026-06-29InterimCVKD
Cadrenal Therapeutics, Inc. names John P. Sharp interim CFO
4 months ago· 2026-06-29TransitionGCO
Genesco Inc. CFO transition: Jonathan Collins to succeed Mimi E. Vaughn
4 months ago· 2026-06-29TransitionTNYA
Tenaya Therapeutics, Inc. CFO transition: Eric Hyllengren, M.B.A. to succeed Faraz Ali, M.B.A.
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26
Something wrong about Jason Knoblauch? Send a correction with the primary source.